The proper regulation of generative AI solutions is one of the challenges facing both vendors and regulators alike, with vendors’ development and commercialisation efforts slowed by a lack of regulatory frameworks. Concurrently regulators fear that some currently unregulated products should undergo greater scrutiny.
Utah is offering one solution to this problem, becoming the first state to establish a permanent office of artificial intelligence. The office has been set up to protect consumers from overreaching solutions, while also hoping to foster innovation in the state. The office will also put forward legislative proposals to the state house.
Why we are covering this topic
– Regulation is one of the biggest barriers to the broader clinical application of generative AI.
– Without solid regulation, there is the potential for some harmful solutions to be offered, or for innovation to be stifled.
Why it matters
– Creating a stable regulatory landscape is key to supporting the development and commercialisation of clinical generative AI tools.
– Regulation could lag behind vendors’ innovation, allowing products which could necessitate regulatory scrutiny, being commercialised regardless.
– With an absence of federal oversight, state-level regulation could become common in the interim.